These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE. Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [Abstract] [Full Text] [Related]
4. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines. Muszynski KW, Ruscetti FW, Gooya JM, Linnekin DM, Keller JR. Stem Cells; 1997 Apr; 15(1):63-72. PubMed ID: 9007224 [Abstract] [Full Text] [Related]
5. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P. Leukemia; 1993 Aug; 7(8):1191-8. PubMed ID: 7688839 [Abstract] [Full Text] [Related]
7. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs. Tafuri A, Lemoli RM, Chen R, Gulati SC, Clarkson BD, Andreeff M. Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244 [Abstract] [Full Text] [Related]
8. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures. Lemoli RM, Gulati SC. Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721 [Abstract] [Full Text] [Related]
9. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia. Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU. Exp Hematol; 1992 Jun; 20(5):558-64. PubMed ID: 1587302 [Abstract] [Full Text] [Related]
11. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells. De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J. Behring Inst Mitt; 1988 Aug; (83):301-7. PubMed ID: 3071344 [Abstract] [Full Text] [Related]
12. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells. Van Der Lely N, De Witte T, Muus P, Raymakers R, Preijers F, Haanen C. Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291 [Abstract] [Full Text] [Related]
15. Experimental basis for the use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with acute myeloid leukemia. Wörmann B, Reuter C, Zühlsdorf M, Büchner T, Hiddemann W. Semin Oncol; 1994 Dec; 21(6 Suppl 16):39-43. PubMed ID: 7801145 [Abstract] [Full Text] [Related]
16. The combination of Steel factor and GM-CSF blocks apoptosis induced by retinoic acid and upregulates AP-1 in a human growth factor-dependent cell line. Horie M, Broxmeyer HE. Exp Hematol; 1995 Feb; 23(2):168-73. PubMed ID: 7530213 [Abstract] [Full Text] [Related]